Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial-Reference-Cited by-同舟云学术

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial

Published:2018-01-22 Issue:4 Volume:73 Page:1020-1024
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Pressiat Claire¹²,Hirt Déborah¹²,Treluyer Jean-Marc¹²,Zheng Yi¹²,Morlat Philippe³,Naqvi Alice⁴,Tran Laurent⁵,Viard Jean-Paul⁶⁷,Avettand-Fenoel Véronique⁷⁸,Rouzioux Christine⁷⁸,Meyer Laurence⁵,Cheret Antoine⁷⁹,Hoen B,Bourdeaux C,Delfraissy J F,Goujard C,Amri I,Fourn E,Quertainmont Y,Môle M,Rami A,Durel A,Diemer M,Parrinello M,Allègre T,Lafeuillade A,Hittinger G,Lambry V,Carrerre M,Philip G,Duvivier C,Consigny P H,Charlier C,Shoai M,Touam F,Pialoux G,Slama L,L'Yavanc T,Mathurin P,Adda A,Berrebi V,Salmon D,Chakvetadze E,Tassadit T,Ousseima E,Pietri M P,Levy Y,Lascaux A S,Lelievre J D,Giovanna M,Dominguez S,Dumont C,Katlama C,Valentin M A,Seang S,Schneider L,Kiorza N,Chermak A,Ben Abdallah S,Simon A,Pichon F,Pauchard M,Molina J M,Lascoux C,Ponscarme D,Colin De Verdiere N,Scemla A,De Castro N,Rachline A,Garrait V,Rozenbaum W,Ferret S,Balkan S,Clavel F,Tourdjman M,Lafaurie M,Aslan A,Goguel J,Thierry S M,De Lastours V,Gallien S,Pavie J,Delgado J,Mededji C,Veron R,Abel S,Pierre-François S,Baringhton C,Chennebault J M,Vandamme Y M,Fialaire P,Rehaiem S,Rabier V,Abgueguen P,Morlat P,Vandenhende M A,Bernard N,Lacoste D,Michaux C,Paccalin F,Receveur M C,Caldato S,Delaune J,Ragnaud J M,Neau D,Lacaze-Buzy L,Livrozet J M,Jeanblanc F,Makhloufi D,Brunel Dalmas F,Jourdain J J,Chiarello P,Yeni P,Phung B,Rioux C,Godard C,Louni F,El Alami Talbi N,Catalano G,Guiroy F,Reynes J,Jacquet J M,Fauchere V,Merle C,Lemoine V,Loriette M,Morquin D,Makinson A,Atoui N,Tramoni C,Raffi F,Allavena C,Bonnet B,Bouchez S,Feuillebois N,Brunet-François C,Reliquet V,Mounoury O,Morineau-Le-Houssine P,Billaud E,Brosseau D,Hüe H,Dellamonica P,Vassallo M,Leplatois A,Durant J,Naqvi A,Joulié A,Souala F,Michelet C,Arvieux C,Tattevin P,Leroy H,Revest M,Fily F,Chapplain J M,Ratajczak C M,Gras G,Bernard L,Dailloux J F,Laplantine V,Cuzin L,Marchou B,Larrigue S,Chauveau M,Balsarin F,Obadia M,Chéret A,Bonne S,Huleux T,Ajana F,Alcaraz I,Baclet V,Melliez H,Viget N,De La Tribonniere X,Aissi E,Poissy J,Ravaux I,Vallon A,Varan M,May T,Letranchant L,Burty C,Briaud A,Wassoumbou S,Stenzel M,Bouillon M P,Debab Y,Caron F,Gueit I,Chapuzet C,Borsa Lebas F,Etienne M,Miailhes P,Perpoint T,Senechal A,Schlienger I,Cotte L,Augustin Normand C,Boibieux A,Ferry T,Corsini N,Braun E,Lippran J,Biron F,Chidiac C,Pailhes S,Lipman J,Braun E,Koffi J,Thoirain V,Brochier C,Greder Belan A,Therby A,Monnier S,Ruquet M,Garrait V,Richier L,Prevoteau Du Clary F,

Affiliation:

1. Paris Descartes University, EA 7323, Paris, France

2. Clinical Pharmacology Department, AP-HP Paris Centre Hospital Group, Paris, France

3. Department of Internal Medicine and Infectious Diseases, Saint-André Hospital, CHU de Bordeaux, Bordeaux, France

4. Infectious Diseases Unit, Nice Hospital, Nice, France

5. University Paris Sud Inserm CESP U1018 AP-HP Hôpital de Bicêtre Epidemiology Department Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France

6. Diagnostic and Therapeutic Center, Hôtel-Dieu, AP-HP, Paris, France

7. Université Paris Descartes, Sorbonne Paris Cité, EA, 7327, Paris, France

8. AP-HP, Necker Hospital, Virology Laboratory, Paris, France

9. Internal Medecine Unit, Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France

Publisher

Oxford University Press (OUP)